Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 240

1.

Parametric methods for dynamic 11C-Phenytoin PET studies.

Mansor MS, Yaqub M, Boellaard R, Froklage FE, Vries A, Bakker ED, Voskuyl RA, Eriksson J, Schwarte LA, Verbeek J, Windhorst AD, Lammertsma A.

J Nucl Med. 2016 Sep 22. pii: jnumed.116.178707. [Epub ahead of print]

PMID:
27660142
2.

In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis.

van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, de Haan L, Eriksson J, Lammertsma AA, Kahn RS, van Berckel BN.

NPJ Schizophr. 2016 Aug 31;2:16031. doi: 10.1038/npjschz.2016.31. eCollection 2016.

3.

[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.

de Jong EE, van Elmpt W, Leijenaar RT, Hoekstra OS, Groen HJ, Smit EF, Boellaard R, van der Noort V, Troost EG, Lambin P, Dingemans AC.

Eur J Nucl Med Mol Imaging. 2016 Sep 6. [Epub ahead of print]

PMID:
27600280
4.

PET tracers for imaging of ABC transporters at the blood-brain barrier: Principles and Strategies.

Luurtsema G, Elsinga P, Dierckx R, Boellaard R, van Waarde A.

Curr Pharm Des. 2016 Aug 10. [Epub ahead of print]

PMID:
27568733
5.

Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol.

Verburg N, Pouwels PJ, Boellaard R, Barkhof F, Hoekstra OS, Reijneveld JC, Vandertop WP, Wesseling P, de Witt Hamer PC.

Neurosurgery. 2016 Oct;79(4):535-40. doi: 10.1227/NEU.0000000000001355.

PMID:
27479710
6.

An automatic delineation method for bone marrow absorbed dose estimation in (89)Zr PET/CT studies.

Makris NE, Boellaard R, Menke CW, Lammertsma AA, Huisman MC.

EJNMMI Phys. 2016 Dec;3(1):13. doi: 10.1186/s40658-016-0149-0. Epub 2016 Jul 22.

7.

Investigation of practical initial attenuation image estimates in TOF-MLAA reconstruction for PET/MR.

Cheng JC, Salomon A, Yaqub M, Boellaard R.

Med Phys. 2016 Jul;43(7):4163. doi: 10.1118/1.4953634.

8.

Parametric binding images of the TSPO ligand [18F]DPA-714.

Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Te Beek ET, Groeneveld GJ, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne J.

J Nucl Med. 2016 Jun 3. pii: jnumed.116.173013. [Epub ahead of print]

PMID:
27261521
9.

Accuracy and precision of partial volume correction in oncological PET/CT studies.

Cysouw MC, Kramer GM, Hoekstra OS, Frings V, de Langen AJ, Smit EF, van den Eertwegh AJ, Oprea-Lager DE, Boellaard R.

J Nucl Med. 2016 May 26. pii: jnumed.116.173831. [Epub ahead of print]

PMID:
27230933
10.

158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin.

Jong EE, Van Elmpt W, Leijenaar RT, Groen H, Smit E, Boellaard R, Noort VV, Troost EG, Lambin P, Dingemans AM.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S126-7. doi: 10.1016/S1556-0864(16)30268-4. Epub 2016 Apr 15. No abstract available.

PMID:
27198295
11.

Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.

van Helden EJ, Hoekstra OS, Boellaard R, Roth C, Mulder ER, Verheul HM, Menke-van der Houven van Oordt CW.

PLoS One. 2016 May 19;11(5):e0155178. doi: 10.1371/journal.pone.0155178. eCollection 2016.

12.

Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.

Kramer GM, Frings V, Hoetjes N, Hoekstra OS, Smit EF, de Langen AJ, Boellaard R.

J Nucl Med. 2016 Sep;57(9):1343-9. doi: 10.2967/jnumed.115.170225. Epub 2016 Apr 21.

PMID:
27103020
13.

Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study.

Hagen PV, Heijl MV, Henegouwen MI, Boellaard R, Bossuyt PM, Kate FJ, Dekken HV, Hoekstra OS, Sloof GW, Lanschot JJ.

Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12479. [Epub ahead of print]

PMID:
27001344
14.

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.

van Velden FH, Kramer GM, Frings V, Nissen IA, Mulder ER, de Langen AJ, Hoekstra OS, Smit EF, Boellaard R.

Mol Imaging Biol. 2016 Oct;18(5):788-95. doi: 10.1007/s11307-016-0940-2.

15.

Quantitative agreement between [(15)O]H2O PET and model free QUASAR MRI-derived cerebral blood flow and arterial blood volume.

Heijtel DF, Petersen ET, Mutsaerts HJ, Bakker E, Schober P, Stevens MF, van Berckel BN, Majoie CB, Booij J, van Osch MJ, van Bavel ET, Boellaard R, Lammertsma AA, Nederveen AJ.

NMR Biomed. 2016 Apr;29(4):519-26. doi: 10.1002/nbm.3480. Epub 2016 Feb 15.

PMID:
26876426
16.

Quantitative and Simplified Analysis of 11C-Erlotinib Studies.

Yaqub M, Bahce I, Voorhoeve C, Schuit RC, Windhorst AD, Hoekstra OS, Boellaard R, Hendrikse NH, Smit EF, Lammertsma AA.

J Nucl Med. 2016 Jun;57(6):861-6. doi: 10.2967/jnumed.115.165225. Epub 2016 Feb 4.

PMID:
26848174
17.

Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.

van Es SC, Venema CM, Glaudemans AW, Lub-de Hooge MN, Elias SG, Boellaard R, Hospers GA, Schröder CP, de Vries EG.

J Nucl Med. 2016 Feb;57 Suppl 1:96S-104S. doi: 10.2967/jnumed.115.157974. Review.

PMID:
26834109
18.

Developments in oncological positron emission tomography/computed tomography assessment.

Kobe C, Boellaard R, Wolf J, Kuhnert G, Dietlein M, Neumaier B, Drzezga A, Kahraman D.

J Thorac Dis. 2015 Dec;7(12):E637-9. doi: 10.3978/j.issn.2072-1439.2015.12.45. No abstract available.

19.

Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.

Lambrecht M, Melidis C, Sonke JJ, Adebahr S, Boellaard R, Verheij M, Guckenberger M, Nestle U, Hurkmans C.

Radiat Oncol. 2016 Jan 20;11:7. doi: 10.1186/s13014-015-0567-5.

20.

Cerebral microglia activation in hepatitis C virus infection correlates to cognitive dysfunction.

Pflugrad H, Meyer GJ, Dirks M, Raab P, Tryc AB, Goldbecker A, Worthmann H, Wilke F, Boellaard R, Yaqub M, Berding G, Weissenborn K.

J Viral Hepat. 2016 May;23(5):348-57. doi: 10.1111/jvh.12496. Epub 2016 Jan 15.

PMID:
26768955
Items per page

Supplemental Content

Loading ...
Write to the Help Desk